- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Global Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
2050
Companies with a Value score of at least 3, ordered by Value score
2050 companies
Spectrum Pharmaceuticals
Market Cap: €209.9m
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology drug products.
NTR
€0.93
7D
0.5%
1Y
11.6%
Trajan Group Holdings
Market Cap: AU$126.5m
Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India.
TRJ
AU$0.82
7D
-1.8%
1Y
-6.8%
BioArctic
Market Cap: SEK 15.5b
Develops biological drugs for patients with central nervous system disorders in Sweden.
0RV2
SEK 175.10
7D
-14.2%
1Y
-23.5%
Royalty Pharma
Market Cap: US$18.4b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPRX
US$32.63
7D
-0.6%
1Y
23.6%
Vetoquinol
Market Cap: €865.8m
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
0O1O
€73.50
7D
-1.5%
1Y
-28.1%
Otsuka Holdings
Market Cap: €3.6t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
OS1
€41.20
7D
2.0%
1Y
14.4%
Amphastar Pharmaceuticals
Market Cap: US$1.2b
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$25.26
7D
4.6%
1Y
-39.3%
Sanofi
Market Cap: €112.8b
A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
1SAN
€92.33
7D
-1.8%
1Y
5.3%
Bristol-Myers Squibb
Market Cap: €95.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BRM
€41.39
7D
-1.6%
1Y
10.1%
Amneal Pharmaceuticals
Market Cap: €2.3b
A global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products worldwide.
2DT
€6.30
7D
-1.6%
1Y
1.6%
Teva Pharmaceutical Industries
Market Cap: €20.3b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEV
€15.75
7D
7.5%
1Y
4.3%
Indivior
Market Cap: €1.1b
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
2IVB
€10.50
7D
4.0%
1Y
-37.9%
Royalty Pharma
Market Cap: €18.4b
Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.
RPD
€28.54
7D
-0.8%
1Y
18.5%
Otsuka Holdings
Market Cap: JP¥3.6t
Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.
4578
JP¥6,902.00
7D
4.0%
1Y
10.3%
WuXi AppTec
Market Cap: CN¥176.2b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥61.65
7D
-0.6%
1Y
45.8%
Sanofi
Market Cap: €112.8b
A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
0O59
€92.62
7D
-1.2%
1Y
5.8%
Anika Therapeutics
Market Cap: US$159.8m
A joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.
ANIK
US$11.12
7D
-5.0%
1Y
-56.6%
Merck
Market Cap: €194.8b
Operates as a healthcare company worldwide.
6MK
€68.60
7D
0.9%
1Y
-41.2%
Sanofi
Market Cap: €112.8b
A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
SANP
€92.70
7D
-1.4%
1Y
5.7%
Sanofi
Market Cap: €112.8b
A healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally.
SAN
€92.62
7D
-1.2%
1Y
5.6%
Merck KGaA
Market Cap: €50.2b
Operates as a science and technology company in Germany.
MRK
€115.35
7D
-2.0%
1Y
-31.5%
Merck
Market Cap: US$194.8b
Operates as a healthcare company worldwide.
MRK
US$76.17
7D
-1.1%
1Y
-39.5%
Catalyst Pharmaceuticals
Market Cap: US$3.0b
A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.
CPRX
US$24.54
7D
0.9%
1Y
54.5%
Bora Pharmaceuticals
Market Cap: NT$79.2b
Researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.
6472
NT$770.00
7D
-3.0%
1Y
5.5%
Mega Lifesciences
Market Cap: ฿21.4b
Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.
MEGA
฿25.00
7D
-1.0%
1Y
-36.7%
Square Pharmaceuticals
Market Cap: ৳177.7b
Manufactures, markets, and sells pharmaceutical products in Bangladesh and internationally.
SQURPHARMA
৳200.50
7D
-4.3%
1Y
-2.6%
Bristol-Myers Squibb
Market Cap: €95.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BRM
€41.00
7D
-2.3%
1Y
9.4%
Selvita
Market Cap: zł600.2m
Operates as a contract research organization worldwide.
SLV
zł32.70
7D
-6.0%
1Y
-50.6%
Vetoquinol
Market Cap: €865.8m
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
VETO
€73.40
7D
-2.0%
1Y
-27.8%
Laboratorios Farmaceuticos Rovi
Market Cap: €2.7b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
0ILL
€52.72
7D
-0.5%
1Y
-40.9%
Merck KGaA
Market Cap: €50.2b
Operates as a science and technology company in Germany.
0O14
€116.95
7D
2.3%
1Y
-30.3%
Dong-A Socio Holdings
Market Cap: ₩695.1b
Engages in the pharmaceutical business in South Korea.
A000640
₩111,400.00
7D
7.9%
1Y
11.6%
Genomma Lab Internacional. de
Market Cap: €21.7b
Provides pharmaceutical and personal care products primarily in Mexico and internationally.
GEKA
€0.99
7D
5.3%
1Y
9.3%
Towa Pharmaceutical
Market Cap: JP¥152.6b
Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.
4553
JP¥3,085.00
7D
4.7%
1Y
9.3%
Hugel
Market Cap: ₩3.3t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩327,500.00
7D
-8.0%
1Y
70.3%
Yunnan Baiyao GroupLtd
Market Cap: CN¥100.5b
Engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally.
000538
CN¥56.28
7D
-0.7%
1Y
5.9%